Immunocompromised individuals & Covid jabs: What you're not being told

Do you remember March 5, 2021? I do, because it was the day this article caught my attention: South Australian doctor receives first AstraZeneca vaccination shot in Australia – (ABC News). My eye was drawn to a particular statement made by the featured doctor, and also the fact that ABC decided to use this as the headline quote:

“I am immunocompromised myself … it's really important to have that health protection not only for myself, not only for my workers but also for the people who we serve, which is the public.”

One wonders, did the featured doctor actually read the Product Information from AstraZeneca prior to making this statement? Did the journalist examine the Product Information before deciding to highlight this statement? Either way, here's what both the doctor and the media outlet failed to mention:

“The immunogenicity, efficacy and safety of COVID-19 Vaccine AstraZeneca has not been assessed in immunocompromised individuals, including those receiving immunosuppressive therapy. The immunogenicity of vaccines may be lower in immunosuppressed patients.” (Sect. 4.4, p. 4)

Now, wouldn't you think it's a good idea – if you're being honest, responsible and indeed, professional – to inform immunocompromised people that the vaccine you are promoting to them has “not been assessed” for “efficacy and safety”? “Okay”, I know you're thinking, “I'll just take one of the other vaccines instead; surely they have been tested more thoroughly?” Let's find out.

What does Pfizer say?:

“The efficacy, safety and immunogenicity of COMIRNATY has not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of COMIRNATY may be lower in immunosuppressed individuals.” (Sect. 4.4, p. 7)

No luck there. What about Janssen Biotech?:

“The efficacy, safety and immunogenicity of the vaccine have not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of COVID-19 Vaccine Janssen may be lower in immunosuppressed individuals.” (Sect. 4.4, p. 3)

Lucky last. Moderna?

“The efficacy, safety and immunogenicity of the vaccine has not been assessed in immunocompromised individuals, including those receiving immunosuppressant therapy. The efficacy of SPIKEVAX may be lower in immunosuppressed individuals.” (Sect. 4.4, p. 6)

Well, there you have it. Not one Covid vaccine listed for use on the Australian population has any safety data assessment for immunocompromised individuals. If you're immunocompromised, don't expect the media and/or the medical profession to inform you of the lack of relevant safety data.